Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 504.00
Bid: 502.00
Ask: 504.00
Change: -5.00 (-0.98%)
Spread: 2.00 (0.398%)
Open: 502.00
High: 511.00
Low: 501.00
Prev. Close: 509.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of 2023 AGM

18 May 2023 07:00

RNS Number : 8044Z
Conduit Holdings Limited
18 May 2023
 

Conduit Holdings Limited - Results of 2023 AGM

 

Conduit Holdings Limited ("CHL") (Ticker:CRE)

 

Pembroke, Bermuda - 18 May 2023

Results of 2023 AGM

Conduit Holdings Limited announces the result of voting on the resolutions at its 2023 Annual General Meeting ('AGM') held on Wednesday 17 May 2023. The meeting considered the 17 resolutions as set out in the AGM Notice dated 17 April 2023.

Each of the resolutions was duly passed by the required majority. Resolutions 1 to 14 were passed as ordinary resolutions. Resolutions 15, 16 and 17 were passed as special resolutions. The total number of votes received for each resolution is set out below.

A copy of the special resolutions passed will be submitted to the National Storage Mechanism and available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

On the voting record date, 15 May 2023, CHL held 757,823 of its common shares in treasury and had 165,239,997 common shares in issue (including treasury shares). Therefore, the total voting rights in CHL on 15 May 2023 was 164,482,174.

 

Votes For

% Votes Cast

Votes Against

% Votes Cast

Votes Withheld

Total Votes Cast (excluding Votes Withheld)

% of ISC voted

1. To receive the Company's audited consolidated financial statements for the financial period ended 31 December 2022 and the reports of the Directors and the Auditors thereon (the "Annual Report and Accounts").

145,607,403

100.00%

0

0

65,091

145,672,403

 

88%

2. To approve the annual report on remuneration as set out in the Annual Report and Accounts for the year ended 31 December 2022

144,204,130

98.99%

1,468,364

1.01%

0

145,672,494

88%

3.To re-elect Neil Eckert as a Director of the Company.

144,156,989

98.96%

1,515,505

1.04%

0

145,672,494

88%

4. To re-elect Trevor Carvey as a Director of the Company.

145,672,494

100.00%

0

0

0

145,672,494

88%

5. To re-elect Elaine Whelan as a Director of the Company.

145,630,802

99.97%

41.692

0.03%

0

145,672,494

88%

6. To re-elect Sir Brian Williamson as a Director of the Company.

145,616,826

99.96%

55,668

0.04%

0

145,672,494

88%

7. To re-elect Malcolm Furbert as a Director of the Company.

145,616,826

99.96%

55,668

0.04%

0

145,672,494

88%

8. To re-elect Elizabeth Murphy as a Director of the Company.

145,635,190

99.97%

37,304

0.03%

0

145,672,494

88%

9. To re-elect Dr Richard L. Sandor as a Director of the Company.

145,616,826

99.96%

55,668

0.04%

0

145,672,494

88%

10. To re-elect Ken Randall as a Director of the Company.

145,616,826

99.96%

55,668

0.04%

0

145,672,494

88%

11. To re-elect Michelle Seymour Smith as a Director of the Company

145,635,190

99.97%

37,304

0.03%

0

145,672,494

88%

12. To re-appoint KPMG Audit Limited as auditors of the Company to hold office until the conclusion of the next general meeting of the Company at which accounts are laid.

145,672,494

100.00%

0

0

0

145,672,494

88%

13. To authorise the Directors to determine the remuneration of the auditors.

 

145,672,494

100.00%

0

0

0

145,672,494

88%

14. Directors' Authority to Allot Shares, as detailed in the Notice of Meeting.

145,289,699

99.74%

382,795

.26%

0

145,672,494

88%

SPECIAL RESOLUTIONS

 

 

 

 

 

 

 

15. Disapplication of Pre-emption Rights - 10% unrestricted as detailed in the Notice of Meeting.

143,726,983

98.66%

1,945,511

1.34%

0

145,672,494

88%

16. Disapplication of Pre-emption Rights - 10% for acquisition or a specified capital investment as detailed in the Notice of Meeting..

140,239,613

96.27%

5,432,881

3.73%

0

145,672,494

88%

17. To authorise the purchase of own Common Shares as detailed in the Notice of Meeting.

143,960,672

98.97

1,450,000

1.00

261,822

145,465,672

88%

 

Media contacts

H/Advisors Maitland - Vikki Kosmalska / Alistair de Kare-Silver

+44 (0) 207 379 5151

conduitre@h-advisors.global

 

Investor relations and other enquiries:

info@conduitreinsurance.com

 

Panmure Gordon (UK) Limited (Joint Corporate Broker)

+44 (0) 207 886 2500

 

Berenberg (Joint Corporate Broker)

+44 (0) 203 207 7800

 

Peel Hunt (Joint Corporate Broker)

+44 (0) 207 418 8900

 

About Conduit Re

Conduit Re is a pure-play Bermuda-based reinsurance business with global reach. Conduit Reinsurance Limited is licensed by the Bermuda Monetary Authority as a Class 4 insurer. A.M. Best has assigned a Financial Strength Rating of A- (Excellent) and a Long-Term Issuer Credit Rating of a- (Excellent) to Conduit Reinsurance Limited. The outlook assigned to these ratings is stable.

Conduit Holdings Limited is the ultimate parent of Conduit Reinsurance Limited and is listed on the London Stock Exchange (ticker: CRE). References to "Conduit" include Conduit Holdings Limited and all of its subsidiary companies.

Learn more about Conduit Re:

Website: https://conduitreinsurance.com/

LinkedIn: https://www.linkedin.com/company/conduit-re

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAFSXFFEDEAA
Date   Source Headline
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSNotice of AGM
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.